Cargando…
Updated Canadian Expert Consensus on Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease
PURPOSE: The purpose of this article is to update the previously published consensus recommendations from March 2017 discussing the optimal management of adult patients with autosomal dominant polycystic kidney disease (ADPKD). This document focuses on recent developments in genetic testing, renal i...
Autores principales: | Soroka, Steven, Alam, Ahsan, Bevilacqua, Micheli, Girard, Louis-Philippe, Komenda, Paul, Loertscher, Rolf, McFarlane, Philip, Pandeya, Sanjaya, Tam, Paul, Bichet, Daniel G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187423/ https://www.ncbi.nlm.nih.gov/pubmed/30345064 http://dx.doi.org/10.1177/2054358118801589 |
Ejemplares similares
-
Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease: A Canadian Expert Consensus
por: Soroka, Steven, et al.
Publicado: (2017) -
Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD)
por: Dudley, Jan, et al.
Publicado: (2019) -
Evidence-based clinical practice guidelines for polycystic kidney disease 2014
por: Horie, Shigeo, et al.
Publicado: (2016) -
Expert consensus on management of metabolic disease in Chinese liver transplant recipients
por: Shen, Tian, et al.
Publicado: (2020) -
ICS/Ultra LABA in the Treatment of Obstructive Airway Diseases: A Consensus of Indian Experts
por: Dhar, Raja, et al.
Publicado: (2022)